Introduction: The role of oxidative stres in patients with Meniere disease (MD), is still unresearched.
The aim: The aim was to compare serum levels of total and direct bilirubin, albumins, uric acid and creatinine as antioxidative status parameters in patients with MD with healthy controls, and patients with multiple sclerosis (MS).
Methods: We divided patients in three groups - 85 MD patients, 75 healthy controls (HC) and 72 MS patients. Patients with MD were divided into groups according to sex, age at the time of the disease onset, and number of attacs per year. Severity of clinical presentation during the attack was assessed by Vertigo Symptom Scale.
Results: The serum levels of all parameters were significantly lower in MD and MS group compared to the healthy control group (p<0.05). Regarding severity of clinical presentation we found strong correlation (p<0.001) which indicates lower antioxidant status in patients with severe clinical presentation.
Conclusion: The results of our research showed significantly lower values of all investigated parameters in MD group related to the healthy controls, which could suggest a potential role of oxidative process in MD patophysiology.
Sajjadi H, Paparella MM. Meniere’s disease. Vol. 372, Lancet. p. 406–14.
2.
Pierce NE, Antonelli PJ. Endolymphatic hydrops perspectives. Vol. 20, Current Opinion in Otolaryngology & Head and Neck Surgery. p. 416–9.
3.
Paparella MM. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere’s disease and its symptoms (mechanical and chemical. Vol. 99, Acta Otolaryngol (Stockh. p. 445–51.
4.
Matsuoka H, Kwon SS, Yazawa Y, Barbieri M, Yoo TJ. Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide. Vol. 111, Ann Otol Rhinol Laryngol. p. 587–92.
5.
Hietikko E, Sorri M, Männikkö M, Kotimäki J. Higher prevalence of autoimmune diseases and longer spells of vertigo in patients affected with familial Ménière’s disease: A clinical comparison of familial and sporadic Ménière’s disease. Vol. 23, American Journal of Audiology. p. 232–7.
6.
Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al. High prevalence of systemic autoimmune diseases in patients with Meniere’s disease. Vol. 6. p. 1–7.
7.
Yoo TJ, J S, Ge X, Kwon SS, Yazawa Y, Sener O, et al. Presence of autoantibodies in the sera of Ménière’s disease. Vol. 110, Ann Otol Rhinol Laryngol. p. 425–9.
8.
Brambilla D, Mancuso C, Scuderi MR, Bosco P, Cantarella G, Lempereur L, et al. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Vol. 7, Nutr J. p. 29–37.
9.
Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Vol. 142, Br J Pharmacol. p. 231–55.
10.
Jangi S, Otterbein L, Robson S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Vol. 45, Int J Biochem Cell Biol. p. 2843–5.
11.
Peng F, Deng X, Yu Y, Chen X, Shen L, Zhong X, et al. Serum bilirubin concentrations and multiple sclerosis. Vol. 18, J Clin Neurosci. p. 1355–9.
12.
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. Vol. 582, FEBS Lett. p. 1783–7.
13.
Tetik S, Kilic A, Aksoy H, Rizaner N, Ahmad S, Yardimci T. Oxidative stress causes plasma protein modification. Vol. 53, Indian J Exp Biol. p. 25–30.
14.
Jansen EH, Beekhof PK, Cremers JW, Viezeliene D, Muzakova V, Skalicky J. Long-term stability of parameters of antioxidant status in human serum. Vol. 47, Free Radic Res. p. 535–40.
15.
Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Vol. 63, Diabetes. p. 976–81.
16.
Kondo M, Kiyomizu K, Goto F, Kitahara T, Imai T, Hashimoto M, et al. Analysis of vestibular-balance symptoms according to symptom duration: dimensionality of the Vertigo Symptom Scale-short form. Vol. 13, Health Qual Life Outcomes. p. 4–14.
17.
Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière’s disease. Vol. 25, J Vestib Res. p. 1–7.
18.
Mantero V, Abate L, Balgera R, Mantia L, Salmaggi A. Clinical application of 2017 McDonald diagnostic criteria for multiple sclerosis. Vol. 14, J Clin Neurol. p. 387–92.
19.
Labbe D, Teranishi MA, Hess A, Bloc W, Michel O. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Vol. 202, Hear Res. p. 21–7.
20.
Capaccio P, Pignataro L, Gaini LM, Sigismund PE, Novembrino C, Giuseppe R, et al. Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Vol. 269, Eur Arch Otorhinolaryngol. p. 449–53.
21.
Calabrese V, Cornelius C, Maiolino L, Luca M, Chiaramonte R, Toscano MA, et al. Oxidative stress, redox homeostasis, and cellular stress response in Meniere’s disease: role of vitagenes. Vol. 35, Neurochem Res. p. 2208–17.
22.
Ozer F, Unal OF, Atas A, Tekin O, Sungur A, Ayas K. Evaluation of the effect of dexamethasone in experimentally induced endolymphatic hydrops in guinea pigs. Vol. 29, Am J Otolaryngol. p. 88–93.
23.
Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras MA, Gonzalez-Perez O. Oral administration of prednisone to control refractory vertigo in Meniere’s disease: a pilot study. Vol. 26, Otol Neurotol. p. 1022–6.
24.
Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, Yoshida T, et al. Polymorphisms in genes involved in oxidative stress response in patients with sudden sensorineural hearing loss and Meniere’s disease in a Japanese population. Vol. 31, DNA Cell Biol. p. 1555–62.
25.
Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease. Vol. 25, Clin Otolaryngol. p. 535–41.
26.
Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, Vincentiis M. Meniere’s disease might be an autoimmune condition? Vol. 11, Autoimmunity Reviews. p. 731–8.
27.
Kim SH, Kim JY, Lee HJ, Gi M, Kim BG, Choi JY. Autoimmunity as a candidate for the etiopathogenesis of Meniere’s disease: detection of autoimmune reactions and diagnostic biomarker candidate. Vol. 9, PLoS One.
28.
Takumida M, Takeda T, Takeda S, Kakigi A, Nakatani H, Anniko M. Protective effect of edaravone against endolymphatic hydrops. Vol. 127, Acta Otolaryngol. p. 1124–31.
29.
Takumida M, Anniko M, Ohtani M. Radical scavengers for Ménière’s disease after failure of conventional therapy: a pilot study. Vol. 123, Acta Otolaryngol. p. 697–703.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
